Chronic Obstructive Pulmonary Disease (COPD) Research
Chronic Obstructive Pulmonary Disease (COPD) Research is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 70k research works in it since 1950. 15.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the standardisation, diagnosis, and management of Chronic Obstructive Pulmonary Disease (COPD), including the use of spirometry for lung function testing, global burden analysis, exacerbation frequency, and the development of guidelines for treatment and prevention. It also explores the relationship between COPD and systemic inflammation, comorbidities, and mortality.
- COPD
- spirometry
- lung function
- pulmonary disease
- global burden
- respiratory
- obstruction
- exacerbations
- management
- diagnosis
- Research works
- 70k fractional, since 1950
- In the world top 10%
- 11k per year above
- Top-10% rate
- 15.1% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +20% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Chronic Obstructive Pulmonary Disease (COPD) Research research?
By volume, the United States and China publish the most (2.6k and 2k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.6k works
- 2 China 2k works
- 3 United Kingdom 1.1k works
- 4 India 664 works
- 5 Spain 483 works
- 6 Italy 452 works
- 7 Germany 444 works
- 8 Canada 433 works
- 9 Japan 418 works
- 10 Brazil 406 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Chronic Obstructive Pulmonary Disease (COPD) Research research?
By volume in 2022–2025, Imperial College London publishes the most Chronic Obstructive Pulmonary Disease (COPD) Research research, followed by University of North Carolina at Chapel Hill and Brigham and Women's Hospital.
By volume, 2022–2025
- 1 Imperial College LondonUnited Kingdom 76 works
- 2 University of North Carolina at Chapel HillUnited States 56 works
- 3 Brigham and Women's HospitalUnited States 53 works
- 4 University of Alabama at BirminghamUnited States 50 works
- 5 Guangzhou Medical UniversityChina 43 works
- 6 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 40 works
- 7 Sichuan UniversityChina 40 works
- 8 Johns Hopkins UniversityUnited States 39 works
- 9 InsermFrance 39 works
- 10 Harvard UniversityUnited States 39 works
Where is Chronic Obstructive Pulmonary Disease (COPD) Research research done?
The largest centres of Chronic Obstructive Pulmonary Disease (COPD) Research research in 2022–2025 are London (United Kingdom), Beijing (China), Guangzhou (China) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Aryanah.
Largest cities, 2022–2025
Where it is the local speciality
- AryanahTN · 38.6 works25×
Location quotient: how much more of its research is in Chronic Obstructive Pulmonary Disease (COPD) Research than the world average.
Where is the best place to study Chronic Obstructive Pulmonary Disease (COPD) Research?
Among universities, judged by research, Guangzhou Medical University, Imperial College London and University of Leicester score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Guangzhou Medical UniversityChina | 61.9 | 21.4% | 12.1× | 43 | +8.5% |
| 2 | Imperial College LondonUnited Kingdom | 61.3 | 18.9% | 6.3× | 76 | +39.9% |
| 3 | University of LeicesterUnited Kingdom | 56.1 | 10.4% | 9.7× | 30 | +67.2% |
| 4 | University of Alabama at BirminghamUnited States | 54.2 | 12.4% | 7.8× | 50 | +73.8% |
| 5 | Chengdu University of Traditional Chinese MedicineChina | 52.2 | 31.3% | 7.3× | 22 | -39.0% |
| 6 | University of Colorado DenverUnited States | 51.4 | 15.5% | 8.2× | 35 | +17.3% |
| 7 | University of Rome Tor VergataItaly | 51.3 | 30.8% | 3.1× | 13 | +160.6% |
| 8 | Umeå UniversitySweden | 51.1 | 10.4% | 8.3× | 27 | +74.9% |
| 9 | Ulsan CollegeSouth Korea | 50.8 | 28.6% | 6.9× | 9 | +93.5% |
| 10 | University of Colorado Anschutz Medical CampusUnited States | 49.4 | 14.3% | 5.7× | 20 | +194.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Chronic Obstructive Pulmonary Disease (COPD) Research research growing?
Output in 2018–2022 was 20% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Chronic Obstructive Pulmonary Disease (COPD) Research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.